VaramirStart free · no cardSign in
TYRA as of Nov 2 · 16:33 ET
TYRANasdaqPharmaceutical Preparations

Tyra Biosciences, Inc. · Brief

Next report

2 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±27.6%
avg realized
±4.7%
Nov 7 '24±15.3%▼−6.06%×0.40
Mar 27 '25±23.6%▲+1.14%×0.05
May 8 '25±55.5%▲+0.20%×0.00
Aug 14 '25±44.1%▲+0.28%×0.01
Nov 5 '25±25.6%▼−3.64%×0.14
Q1 FY26±18.0%▲+1.51%×0.08
May 13 '26±12.3%▲+3.79%×0.31
Q2 FY26±26.7%▼−20.97%×0.78
quarterimplied−60%0+60%realized×
Q2 FY26±26.7%▼−20.97%×0.78
May '26±12.3%▲+3.79%×0.31
Q1 FY26±18.0%▲+1.51%×0.08
Nov '25±25.6%▼−3.64%×0.14
Aug '25±44.1%▲+0.28%×0.01
May '25±55.5%▲+0.20%×0.00
2 older reports
Mar '25±23.6%▲+1.14%×0.05
Nov '24±15.3%▼−6.06%×0.40
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

170managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+8.44%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

4tracked funds holding TYRAN-PORT · Aug 31 '26
0.41%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TYRA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±17.5% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.